0001127602-16-041961.txt : 20160217
0001127602-16-041961.hdr.sgml : 20160217
20160217180321
ACCESSION NUMBER: 0001127602-16-041961
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160212
FILED AS OF DATE: 20160217
DATE AS OF CHANGE: 20160217
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOGEN INC.
CENTRAL INDEX KEY: 0000875045
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330112644
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 225 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 7814642000
MAIL ADDRESS:
STREET 1: 225 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: BIOGEN IDEC INC.
DATE OF NAME CHANGE: 20070427
FORMER COMPANY:
FORMER CONFORMED NAME: BIOGEN IDEC INC
DATE OF NAME CHANGE: 20031112
FORMER COMPANY:
FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE
DATE OF NAME CHANGE: 19970530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCANGOS GEORGE A
CENTRAL INDEX KEY: 0001202102
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19311
FILM NUMBER: 161435371
MAIL ADDRESS:
STREET 1: C/O EXELIXIS INC
STREET 2: 170 HARBOR WAY
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94083
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2016-02-12
0000875045
BIOGEN INC.
BIIB
0001202102
SCANGOS GEORGE A
BIOGEN INC.
225 BINNEY STREET
CAMBRIDGE
MA
02142
1
1
Chief Executive Officer
Common Stock
2016-02-12
4
M
0
4512
0
A
51571
D
Common Stock
2016-02-12
4
F
0
2132
247.22
D
49439
D
Common Stock
2016-02-12
4
M
0
9189
0
A
58628
D
Common Stock
2016-02-12
4
F
0
4324
247.22
D
54304
D
Common Stock
2016-02-12
4
A
0
11390
0
A
65694
D
Common Stock
2016-02-12
4
F
0
5359
247.22
D
60335
D
Common Stock
5378
I
by Trust
Common Stock
5378
I
by Trust
Restricted Stock Unit
0
2016-02-12
4
M
0
4512
0
D
2017-02-12
Common Stock
4512
16484
D
Restricted Stock Unit
0
2016-02-12
4
M
0
9189
0
D
2017-02-12
Common Stock
9189
9182
D
Restricted Stock Unit
0
2016-02-12
4
J
0
5982
0
D
2017-02-12
Common Stock
5982
10502
D
The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).
The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]).
This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.
/s/ Matthew S. Gilman, Attorney in Fact for George A. Scangos
2016-02-17